Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead's Trodelvy and Novartis' Piqray – in England.
Nearly 700,000 women across the country will take part in a world-leading trial to test how AI tools can be used to catch breast cancer cases earlier ...
Today is World Cancer Day, and many of us might be taking a look at our wellbeing. One woman who said she ignored four symptoms at first later found out she had an advanced form of breast cancer ...
chief executive of patient organisation Breast Cancer Now. "Whilst another immunotherapy treatment, atezolizumab, has been available on the NHS since 2020, some patients may be ineligible for this ...